Paper2869952
Relative potency of a beta-blocking and a calcium entry blocking agent as antihypertensive drugs in black patients.
M'Buyamba-Kabangu JR and 6 others. Eur J Clin Pharmacol, 1986. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Relative potency of a beta-blocking and a calcium entry blocking agent as antihypertensive drugs in black patients. Papers, record 2869952. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2869952
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic beta-Antagonists | Major topic |
| Antihypertensive Agents | Major topic |
| Calcium Channel Blockers | Major topic |
| Hypertension | Major topic |
| Acebutolol | |
| Adolescent | |
| Adult | |
| Black or African American | |
| Aged | |
| Body Weight | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Nifedipine | |
| Nitrendipine | |
| Pulse | |
| Random Allocation | |
| Renin | |
| Time Factors |
Source PubMed
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3158325 | The natriuresis following oral administration of the calcium antagonists--nifedipine and nitrendipine. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3158325 | PubMed |
| 2 | 738346 | Acute and chronic effects of nifedipine in arterial hypertension. | Eur J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/738346 | PubMed |
| 3 | 4303266 | Suppressed plasma renin activity in hypertension. | Arch Intern Med | 1969 | https://conductscience.org/library/papers/4303266 | PubMed |
| 4 | 6803871 | Blood pressure and heart rate in patients with ischaemic heart disease receiving nifedipine and propranolol. | Br Med J (Clin Res Ed) | 1982 | https://conductscience.org/library/papers/6803871 | PubMed |
| 5 | 353597 | The treatment of hypertension with verapamil. | N Z Med J | 1978 | https://conductscience.org/library/papers/353597 | PubMed |
| 6 | 371856 | Treatment of hypertension with nifedipine, a calcium antagonistic agent. | Circulation | 1979 | https://conductscience.org/library/papers/371856 | PubMed |
| 7 | 6134671 | Comparison of beta-adrenoceptor blockers and calcium antagonists in hypertension. | Hypertension | 1983 | https://conductscience.org/library/papers/6134671 | PubMed |
| 8 | 7000296 | Trial of atenolol and chlorthalidone for hypertension in black South Africans. | Br Med J | 1980 | https://conductscience.org/library/papers/7000296 | PubMed |
| 9 | 4871610 | Ineffectiveness of propranolol in hypertensive Jamaicans. | Br Med J | 1968 | https://conductscience.org/library/papers/4871610 | PubMed |
| 10 | 6738760 | Intracellular concentration and transmembrane fluxes of sodium and potassium in erythrocytes of normal male subjects. Effect of family history of hypertension and race. | Neth J Med | 1984 | https://conductscience.org/library/papers/6738760 | PubMed |
| 11 | 6184573 | Heterogeneity of systemic hemodynamic response to a new calcium entry blocker, nitrendipine. | J Cardiovasc Pharmacol | 1982 | https://conductscience.org/library/papers/6184573 | PubMed |
| 12 | 5697693 | Metabolic studies on hypertensive patients with suppressed plasma renin activity not due to hyperaldosternosm. | Circulation | 1968 | https://conductscience.org/library/papers/5697693 | PubMed |
| 13 | 6339109 | The effect of nifedipine on arterial pressure and reflex cardiac control. | Circulation | 1983 | https://conductscience.org/library/papers/6339109 | PubMed |
| 14 | 676983 | Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade. | Am Heart J | 1978 | https://conductscience.org/library/papers/676983 | PubMed |
| 15 | 6184574 | Experience with nitrendipine--a new calcium antagonist--in hypertension. | J Cardiovasc Pharmacol | 1982 | https://conductscience.org/library/papers/6184574 | PubMed |
| 16 | 618641 | Faster radioimmunoassay of angiotensin I at 37 degrees C. | Clin Chem | 1978 | https://conductscience.org/library/papers/618641 | PubMed |
| 17 | 5084985 | Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. | N Engl J Med | 1972 | https://conductscience.org/library/papers/5084985 | PubMed |
| 18 | 629266 | The possible importance of aldosterone as well as renin in the long-term antihypertensive action of propranolol. | Am J Med | 1978 | https://conductscience.org/library/papers/629266 | PubMed |
| 19 | 4257928 | Essential hypertension: renin and aldosterone, heart attack and stroke. | N Engl J Med | 1972 | https://conductscience.org/library/papers/4257928 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 3552592 | Nitrendipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension. | Drugs | 1987 | https://conductscience.org/library/papers/3552592 | PubMed |
| 3154705 | Calcium channel antagonists. Part V: Second-generation agents. | Cardiovasc Drugs Ther | 1988 | https://conductscience.org/library/papers/3154705 | PubMed |
| 3154329 | Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications. | Cardiovasc Drugs Ther | 1988 | https://conductscience.org/library/papers/3154329 | PubMed |
| 1283579 | Choosing the correct drug for the individual hypertensive patient. | Drugs | 1992 | https://conductscience.org/library/papers/1283579 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| REN | 5972 | PubTator's text mining | https://conductscience.org/library/genes/5972 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2869952
GET https://conductscience.org/api/papers/v1/2869952/authors